ADMA Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
ADMA Biologics Inc. Stock Analysis ADMA
United States Health Care Mid Cap ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey. The company went IPO on 2013-10-17. The firm manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV (immune globulin intravenous, human - slra 10% liquid) for the treatment of PI, and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
Read More ADMA Chart
ADMA Biologics Inc vs S&P 500 Comparative Returns
Analysis of ADMA stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- ADMA Biologics ... (ADM...) 23.62%
- S&P 500 -4.27%
ADMA Biologics Inc Outperformed S&P 500 by 27.89%
1Y Performance
- ADMA Biologics ... (ADM...) 209.04%
- S&P 500 8.86%
ADMA Biologics Inc Outperformed S&P 500 by 200.18%
3Y Performance
- ADMA Biologics ... (ADM...) 1276.62%
- S&P 500 37.21%
ADMA Biologics Inc Outperformed S&P 500 by 1239.41%
5Y Performance
- ADMA Biologics ... (ADM...) 777.85%
- S&P 500 92.3%
ADMA Biologics Inc Outperformed S&P 500 by 685.55%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$20.72Volume
14.15MP/E Ratio (TTM)
25.7252 Week Range
Market Cap
4.83BAvg. Volume
4.33MDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 0.4 | 0.41 | 0.69 | 1.14 | - |
EBIT per Share (TTM) | -0.62 | -0.3 | -0.18 | 0.1 | - |
Earnings per Share (EPS) (TTM) | - | -0.51 | 0 | 0 | - |
EPS Forward | - | -0.51 | -0.33 | -0.13 | - |
Super Investors
Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
